»ó´Ü¿©¹é
HOME Çコ¶óÀÌÇÁ ÇÇÇà µ¿Á¤
±â»çÀα⵵
Á¶À±Á¤,¤ý³²¹ÎÁ¤ ±³¼ö, Áø´Ü¸é¿ªÇÐȸ ¿ì¼ö¿¬Á¦»ó
ÇコÆ÷Ä¿½º / ÇコÆ÷Ä¿½º´º½º | ½ÂÀÎ2022.05.19 0:10

°í´ë¾È¾Ïº´¿ø Áø´Ü°Ë»çÀÇÇаú Á¶À±Á¤, ³²¹ÎÁ¤ ±³¼ö°¡ Áö³­ 4¿ù 27ÀÏ °³ÃÖµÈ ‘2022 ´ëÇÑÁø´Ü¸é¿ªÇÐȸ Ãá°èÇмú´ëȸ’¿¡¼­ ¿ì¼ö¿¬Á¦»óÀ» ¼ö»óÇß´Ù.

Á¶À±Á¤ ±³¼ö¿Í ³²¹ÎÁ¤ ±³¼ö´Â SARS-CoV-2¹ÙÀÌ·¯½º¿¡ ´ëÇÑ º¤Å͹é½Å, È¥ÇÕ¹é½Å, mRNA ¹é½Å Á¢Á¾±º¿¡¼­ ü¾×¼º ¹× ¼¼Æ÷¼º ¸é¿ª¹ÝÀÀ¿¡ ¹ÌÄ¡´Â ¿äÀÎ(Factors Affecting Humoral and Cellular Immune Responses to Vector, Mix-and-match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses)À» ±Ô¸íÇØ À̹ø ¼ö»óÀÇ ÁÖÀΰøÀÌ µÆ´Ù.

Á¶À±Á¤ ±³¼ö´Â “´Ü±â°£ ³»¿¡ ¼¼°èÀû À¯ÇàÀ» ÃÊ·¡ÇÑ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)¿¡ ´ëÇØ ¹ü±¹°¡ÀûÀ¸·Î ½Å¼ÓÇÏ°Ô ¿¹¹æ ¹× Ä¡·áÀü·«À» ±¸ÃàÇØ ½ÇÇàÇß´ø °Íó·³ ¹é½Å Á¢Á¾ È¿°ú¿¡ ´ëÇÑ ´ë±Ô¸ð ºÐ¼®ÀÌ ÇʼöÀûÀ̹ǷΠÇâÈÄ ¹é½Å Á¢Á¾ÀÚ¿¡¼­ÀÇ µ¹ÆÄ°¨¿°¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀο¡ ´ëÇÑ Ãß°¡ ºÐ¼®À» ÁøÇàÇÒ ¿¹Á¤ÀÌ´Ù.”¶ó¸ç, “¿¬±¸°á°ú°¡ ÇâÈÄ ½ÅÁ¾Àü¿°º´¿¡ ´ëÇÑ ¹é½ÅÁ¤Ã¥ ¼ö¸³‘¿¡ Áß¿äÇÑ ±âÃÊÀÚ·á°¡ µÉ °ÍÀÌ´Ù.”¶ó°í ¼³¸íÇß´Ù.

ÇコÆ÷Ä¿½º  webmaster@healthfocus.co.kr

<ÀúÀÛ±ÇÀÚ © ÇコÆ÷Ä¿½º´º½º, ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>

ÇコÆ÷Ä¿½ºÀÇ ´Ù¸¥±â»ç º¸±â
iconÁÖ¿ä±â»ç
±â»ç ´ñ±Û 0°³
Àüüº¸±â
ù¹øÂ° ´ñ±ÛÀ» ³²°ÜÁÖ¼¼¿ä.
¿©¹é
Back to Top